Crossmark Global Holdings’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.08M | Sell |
4,151
-76
| -2% | -$36.5K | 0.03% | 449 |
|
|
2026
Q1 | $2.08M | Sell |
4,227
-158
| -4% | -$85.7K | 0.03% | 426 |
|
|
2025
Q4 | $2.54M | Buy |
4,385
+576
| +15% | +$326K | 0.04% | 377 |
|
|
2025
Q3 | $1.85M | Sell |
3,809
-43
| -1% | -$20K | 0.03% | 473 |
|
|
2025
Q2 | $1.56M | Sell |
3,852
-106
| -3% | -$44.3K | 0.03% | 496 |
|
|
2025
Q1 | $1.97M | Sell |
3,958
-267
| -6% | -$145K | 0.03% | 424 |
|
|
2024
Q4 | $2.2M | Sell |
4,225
-1,597
| -27% | -$878K | 0.04% | 380 |
|
|
2024
Q3 | $3.6M | Sell |
5,822
-446
| -7% | -$264K | 0.06% | 286 |
|
|
2024
Q2 | $3.47M | Buy |
6,268
+5
| +0.1% | +$2.86K | 0.07% | 291 |
|
|
2024
Q1 | $3.64M | Buy |
6,263
+143
| +2% | +$80.2K | 0.07% | 281 |
|
|
2023
Q4 | $3.25M | Sell |
6,120
-43
| -0.7% | -$20.8K | 0.07% | 298 |
|
|
2023
Q3 | $3.06M | Buy |
6,163
+1,594
| +35% | +$849K | 0.07% | 291 |
|
|
2023
Q2 | $2.57M | Buy |
4,569
+606
| +15% | +$327K | 0.06% | 349 |
|
|
2023
Q1 | $2.28M | Sell |
3,963
-399
| -9% | -$225K | 0.05% | 369 |
|
|
2022
Q4 | $2.4M | Sell |
4,362
-2,009
| -32% | -$1.06M | 0.06% | 348 |
|
|
2022
Q3 | $3.23M | Sell |
6,371
-102
| -2% | -$57.1K | 0.09% | 249 |
|
|
2022
Q2 | $3.52M | Sell |
6,473
-292
| -4% | -$161K | 0.09% | 250 |
|
|
2022
Q1 | $4M | Sell |
6,765
-110
| -2% | -$63.2K | 0.09% | 244 |
|
|
2021
Q4 | $4.59M | Sell |
6,875
-270
| -4% | -$169K | 0.1% | 216 |
|
|
2021
Q3 | $4.08M | Buy |
7,145
+254
| +4% | +$139K | 0.1% | 224 |
|
|
2021
Q2 | $3.48M | Sell |
6,891
-848
| -11% | -$400K | 0.08% | 254 |
|
|
2021
Q1 | $3.53M | Buy |
7,739
+270
| +4% | +$129K | 0.09% | 240 |
|
|
2020
Q4 | $3.48M | Sell |
7,469
-157
| -2% | -$73.6K | 0.09% | 253 |
|
|
2020
Q3 | $3.37M | Sell |
7,626
-659
| -8% | -$272K | 0.09% | 230 |
|
|
2020
Q2 | $3M | Buy |
8,285
+144
| +2% | +$48.3K | 0.09% | 253 |
|
|
2020
Q1 | $2.31M | Sell |
8,141
-114
| -1% | -$35.9K | 0.08% | 257 |
|
|
2019
Q4 | $2.68M | Sell |
8,255
-1
| -0% | -$303 | 0.07% | 285 |
|
|
2019
Q3 | $2.4M | Sell |
8,256
-1,857
| -18% | -$532K | 0.07% | 310 |
|
|
2019
Q2 | $2.97M | Sell |
10,113
-83
| -0.8% | -$22.9K | 0.08% | 269 |
|
|
2019
Q1 | $2.79M | Sell |
10,196
-387
| -4% | -$96.3K | 0.08% | 282 |
|
|
2018
Q4 | $2.37M | Buy |
10,583
+464
| +5% | +$109K | 0.07% | 303 |
|
|
2018
Q3 | $2.47M | Sell |
10,119
-146
| -1% | -$33.6K | 0.06% | 345 |
|
|
2018
Q2 | $2.13M | Buy |
10,265
+259
| +3% | +$55K | 0.06% | 375 |
|
|
2018
Q1 | $2.07M | Sell |
10,006
-478
| -5% | -$100K | 0.05% | 407 |
|
|
2017
Q4 | $1.99M | Buy |
10,484
+180
| +2% | +$34.5K | 0.05% | 431 |
|
|
2017
Q3 | $1.95M | Buy |
+10,304
| New | +$1.87M | 0.05% | 418 |
|
|
2016
Q3 | $1.95M | Buy |
+10,304
| New | +$1.59M | 0.05% | 418 |
|
Other funds holding TMO
Crossmark Global Holdings's TMO Position: Q2 2026 in Review
Crossmark Global Holdings reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q2 2026, selling an estimated $36.5K and leaving 4,151 shares worth $2.08M. The position accounts for 0.03% of the portfolio, ranked #449.
Crossmark Global Holdings first reported a position in TMO in Q3 2016 and has held it in 37 quarters since. The position peaked at $4.59M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Crossmark Global Holdings held 4,151 shares of Thermo Fisher Scientific worth $2.08M as of Q2 2026.
- Crossmark Global Holdings sold 76 Thermo Fisher Scientific shares in Q2 2026, an estimated $36.5K.
- Thermo Fisher Scientific made up 0.03% of Crossmark Global Holdings's portfolio in Q2 2026, its #449 holding.
- Crossmark Global Holdings first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's Thermo Fisher Scientific position peaked at $4.59M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.